AVITA Medical appoints Cary Vance as interim CEO
Source: SeekingAlpha
2025-10-17 02:09:37 ET
More on AVITA Medical
- AVITA Medical: Reimbursement Reset And Breakeven Path By 2026
- AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- AVITA Medical: Green Shoots Peaking Out From Hard Clay
- Avita Medical stock jumps 10% after securing CE Mark for RECELL GO
- Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases
Read the full article on Seeking Alpha
For further details see:
AVITA Medical appoints Cary Vance as interim CEO
Avita Medical Inc.
NASDAQ: RCEL
RCEL Trading
-3.92% G/L:
$4.775 Last:
43,067 Volume:
$4.86 Open:
RCEL Latest News
February 23, 2026 04:15:00 pm
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 12, 2026 04:01:00 pm
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
RCEL Stock Data
$122,429,841
29,639,304
0.44%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Valencia
